No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA Medical Dialogues Bureau24 Oct 2019 9:20 AM ISTEarly tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
Single-member NCLT bench to give finality to split verdict over Unimark Remedies resolution Medical Dialogues Bureau24 Oct 2019 9:00 AM ISTThe NCLT had initiated Corporate Insolvency Resolution Process against Unimark Remedies on Apri 13, 2018 admitting the plea of the private sector...
DCGI nod to Lincoln pharma Diclofenac Rectal Spray for reducing types of pain Medical Dialogues Bureau23 Oct 2019 4:24 PM ISTThe patent has been awarded by the Government of India for "a novel liquid rectal spray dosage form containing diclofenac and its pharmaceutically...
Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US Medical Dialogues Bureau23 Oct 2019 11:38 AM IST"The United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of...
AstraZeneca Farxiga approved in US to reduce heart failure risk in Type-2 diabetes Medical Dialogues Bureau23 Oct 2019 9:30 AM ISTFarxiga is also under regulatory review in China with a decision anticipated in the first half of 2020, AstraZeneca said in a release.New Delhi:...
CDSCO directs drug regulators to strictly monitor end-use of dual-use APIs Medical Dialogues Bureau22 Oct 2019 5:32 PM ISTNew Delhi: Through a recent Office Memorandum, Central Drugs Standard Control Organisation (CDSCO) has directed drug regulators to strictly monitor...
GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion Medical Dialogues Bureau22 Oct 2019 10:00 AM ISTThe sale of GSK's anti-rabies treatment Rabipur and Encepur, used for the prevention of tick-borne encephalitis, to the Denmark-based biotechnology...
Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC Medical Dialogues Bureau22 Oct 2019 9:50 AM ISTRoche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre Medical Dialogues Bureau22 Oct 2019 9:45 AM ISTThe minister contended that Hyderabad Pharma City is the "world's largest integrated pharma park" to promote domestic manufacturing of pharmaceuticals...
Teva Pharma, 3 others reach tentative deal to settle opioid lawsuit Medical Dialogues Bureau22 Oct 2019 9:00 AM ISTNew Delhi: The US's three dominant drug distributors and a big drugmaker have reached a tentative deal to settle a lawsuit related to the opioid...
Johnson and Johnson wins EMA vote for depression drug Spravato Medical Dialogues Bureau21 Oct 2019 10:15 AM ISTJ&J has said that over 2,000 centres in the U.S. have been certified to administer Spravato, which has been touted as an asset with blockbuster...
Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms Farhat Nasim21 Oct 2019 10:00 AM ISTGranules India's Fexofenadine Hydrochloride tablets USP is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg...
